Publications by authors named "Latorya D Hicks"

Claim this Profile
R
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.
Elizabeth I Parkinson, M Jason Hatfield, Lyudmila Tsurkan, Janice L Hyatt, Carol C Edwards, Latorya D Hicks

Bioorg Med Chem· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11.
M Jason Hatfield, Lyudmila Tsurkan, Michael Garrett, Timothy M Shaver, Janice L Hyatt, Latorya D Hicks

Biochem Pharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.
Latorya D Hicks, Janice L Hyatt, Shana Stoddard, Lyudmila Tsurkan, Carol C Edwards

J Med Chem· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.
Janice L Hyatt, Randy M Wadkins, Lyudmila Tsurkan, Latorya D Hicks, M Jason Hatfield

J Med Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils.
Latorya D Hicks, Janice L Hyatt, Teri Moak, Carol C Edwards, Lyudmila Tsurkan

Bioorg Med Chem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis